Stay updated on Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedCore study metadata changed: the condition 'Multiple Myeloma' and its related topics link were removed. NIH funding notes for 2018 and 2023 were added, and the revision tag updated to v3.6.6.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe related topics section now lists 'Multiple myeloma' and 'MedlinePlus Genetics' as linked topics, tying the study to its disease context and genetics resources.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page now displays an error screen indicating the content is unavailable, replacing the previous study record details, documents, and locations. This change prevents viewing the NCT03652064 study record.SummaryDifference16%

- Check52 days agoChange DetectedAdded 'Multiple myeloma' and related topics including MedlinePlus Genetics. Updated the revision tag from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the page's disease label 'Multiple myeloma' and the related topics section. The 'MedlinePlus Genetics' link was also removed.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.6.3 was added to the page's metadata, replacing the previous Revision: v3.6.2. This reflects a minor update to the page version in the system.SummaryDifference0.0%

Stay in the know with updates to Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.